| Bigtincan Holdings Limited (BTH) ORDINARY FULLY PAID |
Information Technology |
$177 |
FY24 Full Year results presentation
|
29 Aug 2024 8:23AM |
$0.120 |
$0.215 |
risen by
79.17%
|
|
BTH - Price-sensitive ASX Announcement
Full Release
Key Points
- FY24 results highlight an EBITDA of $11.3 million and operating cash flow of $6.2 million.
- The company achieved an 88% gross margin and $117.1 million in total operating revenue.
- Bigtincan identified as a leader in sales enablement with over 2,000 customer deployments globally.
- Strategic focus on AI, particularly GenieAI, to drive productivity and efficiency gains.
- FY25 outlook includes an EBITDA target of $14 million and ARR growth.
- Significant investments planned in market development and product diversification.
- The company completed an equity raising of $20.5 million to support AI technology growth.
- FY24 saw a 136% increase in EBITDA compared to the previous corresponding period.
- Cost base adjustments led to improved profitability with total expenses from operating activities reduced by 20%.
- Key initiatives for FY25 include ongoing diversification, market development, and focus on core customer base to drive growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| One Click Group Limited (1CG) ORDINARY FULLY PAID |
Industrials |
$9 |
YTD Revenue Exceeds Entire CY2023
|
29 Aug 2024 8:23AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
1CG - Price-sensitive ASX Announcement
Full Release
Key Points
- YTD revenue of $3.9 million exceeds entire CY2023 revenue.
- Over 160,000 registered users with 40,000 new users year-to-date.
- Tax services are the main revenue and growth driver.
- Strong retention of existing users validates the business model.
- Managing Director Mark Waller highlights confidence in continued revenue growth for 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Waypoint REIT Limited (WPR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,690 |
Appendix 4D and HY24 Financial Report
|
29 Aug 2024 8:22AM |
$2.590 |
$2.540 |
fallen by
1.93%
|
|
| Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$15,253 |
Qantas Group FY24 Appendix 4E and Preliminary Final Report
|
29 Aug 2024 8:22AM |
$6.320 |
$10.080 |
risen by
59.49%
|
|
QAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Qantas Group reported an Underlying Profit Before Tax of $2,078 million for FY24, a $387 million reduction from FY23.
- Statutory Profit After Tax was $1,251 million, including the impact of the ACCC settlement and associated costs.
- Revenue increased by 10.7% to $21,939 million.
- No dividends were declared or paid during the year ended June 2024.
- Qantas Domestic reported an Underlying EBIT of $1,063 million, a decline of 16% from FY23.
- Qantas International reported an Underlying EBIT of $556 million, a 39% decline from FY23.
- Jetstar Group reported an Underlying EBIT of $497 million, an increase from FY23.
- Qantas Loyalty reported an Underlying EBIT of $511 million.
- Group operating margin was 10%.
- Operating cash flow was $3,441 million.
- Net capital expenditure was $3,148 million.
- Group Unit Revenue fell by 9%.
- Qantas completed $869 million of on-market share buy-backs.
- Total Group ASKs were at 93% of pre-COVID levels.
- Qantas Group fleet totalled 347 aircraft as of June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QuickFee Limited (QFE) ORDINARY FULLY PAID |
Financials |
$17 |
Application for quotation of securities - QFE
|
29 Aug 2024 8:22AM |
$0.070 |
$0.046 |
fallen by
34.29%
|
|
| E&P Financial Group Limited (EP1) ORDINARY FULLY PAID |
Financials |
- |
FY24 Results Announcement
|
29 Aug 2024 8:21AM |
$0.475 |
$0.515 |
risen by
8.42%
|
|
EP1 - Price-sensitive ASX Announcement
Full Release
Key Points
- E&P Financial Group Limited announced its FY24 results.
- The Eloise Copper Mine produced 13,412t of copper in concentrate for the year.
- Eloise achieved an AISC of A$5.15/lb Cu sold and an AIC of A$5.39/lb Cu sold.
- Total copper sales for FY24 were 13,056t, generating $182.2 million in metal sales.
- Operating cashflow for FY24 was $73.2 million, with net mine cashflow of $23.1 million.
- Eloise exceeded its FY24 production target by 7.3%.
- The Eloise to Jericho link drive commenced development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| E&P Financial Group Limited (EP1) ORDINARY FULLY PAID |
Financials |
- |
FY24 Financial Report
|
29 Aug 2024 8:21AM |
$0.475 |
$0.515 |
risen by
8.42%
|
|
| Brazilian Rare Earths Limited (BRE) ORDINARY FULLY PAID |
Materials |
$266 |
Half Yearly Report and Accounts
|
29 Aug 2024 8:21AM |
$2.660 |
$2.360 |
fallen by
11.28%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,791 |
Investor Reference Pack to 30 June 2024
|
29 Aug 2024 8:21AM |
$5.090 |
$5.370 |
risen by
5.50%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Atlas Arteria trades on the Australian Securities Exchange as a stapled security under the code 'ALX'.
- Atlas Arteria's business portfolio includes interests in APRR, ADELAC, Dulles Greenway, Warnow Tunnel, and Chicago Skyway.
- The company provided a detailed analysis of traffic, revenue, and EBITDA for its assets.
- As of 30 June 2024, Atlas Arteria's economic interest in APRR and ADELAC changed to 30.82% and 30.85% respectively following a capital increase at MAF2.
- Atlas Arteria reported on financing and debt metrics for its various assets.
- The report includes maps and detailed descriptions of each toll road asset.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
$50 |
MDR delivers strong revenue growth & inaugural profit
|
29 Aug 2024 8:20AM |
$0.465 |
$0.080 |
fallen by
82.80%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Achieved 24.6% revenue growth to $122.1 million in FY24.
- Reported inaugural EBITDA profit of $7.0 million.
- Marked first NPAT profit of $0.8 million.
- Significant revenue growth in the US, reaching nearly $100 million.
- Expansion of vaccine and chronic medication programs contributed to growth.
- THRiV platform revenues grew more than sevenfold.
- Transformation 360° initiative to launch in FY25.
- 5-year Strategic Plan targets $250 million revenue and 20%+ EBITDA margin by FY28.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,791 |
Half Year Results Investor Presentation to 30 June 2024
|
29 Aug 2024 8:20AM |
$5.090 |
$5.370 |
risen by
5.50%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Atlas Arteria reported their half-year results for the period ending 30 June 2024.
- The company saw a 3.8% increase in toll revenue and a 0.4% increase in traffic.
- Total EBITDA decreased by 2.9%, primarily due to the new French tax (TEILD).
- The company maintained its distribution guidance for 2024 at 40 cents per security.
- Hugh Wehby was appointed as the incoming CEO and Managing Director, starting late 2024.
- Atlas Arteria achieved significant progress on sustainability targets, including a reduction in Scope 1 and 2 emissions.
- Key financial highlights include a proportionate toll revenue increase of 3.8% and total revenue increase of 4.8%.
- The company has implemented a new reporting methodology for centralized costs starting from H1 2024.
- Capital management initiatives include a €200 million cash reserve release to fund debt amortization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| E&P Financial Group Limited (EP1) ORDINARY FULLY PAID |
Financials |
- |
Appendix 4E for the year ended 30 June 2024
|
29 Aug 2024 8:20AM |
$0.475 |
$0.515 |
risen by
8.42%
|
|
EP1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue decreased by 14.7% to $150.48 million.
- Loss for the year after tax attributable to shareholders decreased by 62.6% to $27.679 million.
- Total comprehensive income for the year decreased by 61.3% to $29.434 million.
- No dividends were declared for FY24.
- Net tangible assets per share decreased from $0.24 in 2023 to $0.20 in 2024.
- Basic and diluted loss per share increased from (7.4) cents in 2023 to (12.0) cents in 2024.
- Annual General Meeting scheduled for 12 November 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
$50 |
MDR Appendix 4E and FY24 Annual Report
|
29 Aug 2024 8:20AM |
$0.465 |
$0.080 |
fallen by
82.80%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities increased by 24.7% to $122,261,893
- Profit after tax attributable to owners increased by 107.0% to $792,133
- No dividends were declared or paid during the current financial period
- Net tangible assets per ordinary security improved from (3.45) cents to (2.40) cents
- The financial statements received an unmodified audit opinion
- Total revenue for MedAdvisor in FY24 was $122,105,767
- The company reported a profit of $923,583 before income tax and $792,133 after income tax in FY24
- ANZ operations generated segment revenue of $23,702,363, US operations $98,409,442, and UK operations had a minor loss
- Total assets stood at $98,782,647 and total liabilities at $47,199,214 as of June 30, 2024
- Employee benefits expenses totaled $46,422,376, including wages and share-based remuneration
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QuickFee Limited (QFE) ORDINARY FULLY PAID |
Financials |
$17 |
Notification of cessation of securities - QFE
|
29 Aug 2024 8:19AM |
$0.070 |
$0.046 |
fallen by
34.29%
|
|
| Cettire Limited (CTT) ORDINARY FULLY PAID |
Consumer Discretionary |
$114 |
Rescheduled time of investor webinar for FY24 Results
|
29 Aug 2024 8:19AM |
$1.330 |
$0.300 |
fallen by
77.44%
|
|
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
$50 |
MDR Corporate Governance Statement 2024
|
29 Aug 2024 8:18AM |
$0.465 |
$0.080 |
fallen by
82.80%
|
|
| Doctor Care Anywhere Group PLC (DOC) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$34 |
Future Board Change - Ben Kent
|
29 Aug 2024 8:17AM |
$0.070 |
$0.094 |
risen by
34.29%
|
|
| Pioneer Lithium Limited (PLN) ORDINARY FULLY PAID |
Materials |
$5 |
New Drill Targets Identified Additional Ground at VerdeValor
|
29 Aug 2024 8:17AM |
$0.170 |
$0.110 |
fallen by
35.29%
|
|
PLN - Price-sensitive ASX Announcement
Full Release
Key Points
- Pioneer Lithium Limited completed a 300m exploratory auger drilling campaign at the Verde Valor project.
- The campaign confirmed high-grade Rare Earth Elements (REE) with significant clay intercepts including 2,371ppm and 3,139ppm TREO.
- Focusing on delineating high-grade zones, additional geological and structural mapping will be conducted.
- An extra 2,000 hectares has been staked adjacent to high-grade drill holes.
- Auger drilling results revealed significant REE concentrations, particularly in holes TP-AG-009 and TP-AG-005.
- Future drilling campaigns will include auger, RC, and diamond drilling.
- The company's strategy now includes comprehensive geological mapping and structural analysis to enhance understanding of REE mineralisation.
- Preliminary environmental assessments will be initiated to evaluate the feasibility of REE extraction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fenix Resources Ltd (FEX) ORDINARY FULLY PAID |
Materials |
$208 |
FY24 Annual Report
|
29 Aug 2024 8:16AM |
$0.295 |
$0.280 |
fallen by
5.08%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,000 |
MSB Annual Financial Results and Operational Update
|
29 Aug 2024 8:16AM |
$0.955 |
$1.565 |
risen by
63.87%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Mesoblast resubmitted its BLA for RYONCIL on July 8, 2024.
- FDA accepted the BLA resubmission within two weeks.
- FDA anticipates a decision on RYONCIL by January 7, 2025.
- Mesoblast commenced enrolling patients in a Phase 3 trial for inflammatory back pain.
- FDA granted Rare Pediatric Disease Designation for Revascor in congenital heart disease.
- Mesoblast recognized a loss of US$88.0 million for FY2024.
- Cash balance at June 30, 2024, was US$63.3 million.
- Revenue for FY2024 was US$5.9 million, down from US$7.1 million in FY2023.
- Research & Development expenses reduced by US$1.8 million in FY2024.
- Manufacturing expenses reduced by US$12.0 million in FY2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Silex Systems Limited (SLX) ORDINARY FULLY PAID |
Industrials |
$893 |
Appendix 4G and Corporate Governance Statement
|
29 Aug 2024 8:16AM |
$4.480 |
$3.750 |
fallen by
16.29%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,791 |
Half Year Results Announcement to 30 June 2024
|
29 Aug 2024 8:16AM |
$5.090 |
$5.370 |
risen by
5.50%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- 2024 distribution guidance of 40.0 cents per security reaffirmed
- Strong growth in proportionate toll revenue (+3.8% compared to H1 2023)
- Net corporate free cash flow up 12.7% compared to H1 2023
- Legal challenge to the new French long-distance transportation infrastructure tax (TEILD) ongoing
- APRR and Eiffage consortium awarded A412 motorway project
- Hugh Wehby appointed as incoming CEO and Managing Director commencing late 2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
$50 |
MDR Appendix 4G 2024
|
29 Aug 2024 8:15AM |
$0.465 |
$0.080 |
fallen by
82.80%
|
|
| Bigtincan Holdings Limited (BTH) ORDINARY FULLY PAID |
Information Technology |
$177 |
FY24 Full Year results announcement
|
29 Aug 2024 8:15AM |
$0.120 |
$0.215 |
risen by
79.17%
|
|
BTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant revenue opportunities from GenieAI technology expected in FY25
- FY24 EBITDA increased to $11.3 million from $4.9 million in FY23
- Total FY24 revenue was $117.1 million despite regional revenue declines
- Annualized Recurring Revenue (ARR) reached $116 million
- GenieAI technology launched, contributing $1.5 million to ARR
- 2nd largest deal in company history secured with Align Technologies
- A$20.5 million capital raised to support AI investments
- Customer ARR retention rate of 87% achieved
- FY25 projected to see 20%+ EBITDA growth and increased ARR
- Successful strategic partnerships, including Microsoft 365 Copilot integration
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,791 |
Appendix 4D and Interim Financial Report
|
29 Aug 2024 8:15AM |
$5.090 |
$5.370 |
risen by
5.50%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Interim Financial Reports prepared in accordance with Australian Accounting Standards and IAS 34
- Atlas Arteria (ALX) comprises Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX)
- Net profit after tax attributable to Atlas Arteria stapled securityholders decreased by 16.3% to A$114.2 million
- Revenue and other income increased by 9.6% to A$69.6 million
- Dividends of 20.0 cents per stapled security declared
- Net tangible asset backing per stapled security decreased to A$2.76 from A$2.99
- ALX owns interests in toll roads in France, the US, and Germany
- Toll revenue increased despite decreased traffic numbers due to farmers' strikes in France
- Strategic updates include refinancing debt facilities and releasing trapped cash within the APRR Group
- EBITDA on a proportional basis was €337.7 million for APRR Group in H1 2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
